The Discriminative Properties of the SF-6D Compared With the SF-36 and ODI

被引:15
|
作者
Carreon, Leah Y. [1 ]
Berven, Sigurd H. [2 ]
Djurasovic, Mladen [1 ]
Bratcher, Kelly R. [1 ]
Glassman, Steven D. [1 ]
机构
[1] Norton Leatherman Spine Ctr, Louisville, KY 40202 USA
[2] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA
关键词
health utility; patient-reported outcomes; lumbar fusion; discriminative properties; psychometrics; HEALTH-STATUS INSTRUMENTS; NATURAL-HISTORY; BACK-PAIN; DISABILITY; VALIDATION; EUROQOL; QUESTIONNAIRE; RELIABILITY; STATE;
D O I
10.1097/BRS.0b013e3182609df6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. Longitudinal cohort. Objectives. To determine the discriminate validity of the Short Form-6D (SF-6D) compared with the SF-36 in a cohort of patients with lumbar degenerative disorders. Summary of Background Data. Cost-utility studies are important for the demonstration of comparative effectiveness of treatments for lumbar degenerative disorders. Multidimensional patient-reported outcome tools including the SF-36 and Oswestry Disability Index (ODI) may be limited to measuring the utility of specific health care states. The evaluation of utility is based on single-index preference-based health state scales, such as the SF-6D. The loss of discriminative properties using a single-index compared with a multidimensional score is unknown. Methods. The cohort studies included 1104 patients who had decompression and lumbar fusion with complete ODI, SF-36, and SF-6D data at baseline and 2-year follow-up. Discriminative properties of the 3 measures were compared by computing the effect size (ES) and the standardized response mean (SRM). The larger the ES and SRM, the more sensitive to change the measure is. The relative validity (RV) statistic for each measure was also determined with the SF-6D as reference. Measures that are more sensitive than the SF-6D would have RVs greater than 1.0, those that are less sensitive would have RVs less than 1.0. Results. The ODI had the greatest ES at 0.93 followed by the SF-6D at 0.88 and the SF-36 Physical Composite Score (PCS) at 0.85. The ODI also had the greatest standardized response mean at 0.73 followed by the SF-6D at 0.70 and the SF-36 PCS at 0.57. The RV statistics for both the ODI (1.28) and the SF-36 PCS (1.32) were greater compared with the SF-6D. The SF-36 bodily pain domain had the greatest ES (1.42), SRM (0.81), and RV (1.50). The general health domain had the lowest ES (0.21) and SRM (0.23), whereas mental health domain had the lowest RV. Conclusions. In this cohort of patients, using the single-index SF-6D produces a loss of discriminative properties compared with the SF-36 and ODI. However, this loss is small, because all the effect sizes remain large (>= 0.80). Therefore, these losses should not preclude the use of the SF-6D compared with the SF-36 and may be preferred because it is more easily interpretable and less difficult to incorporate in economic evaluations.
引用
下载
收藏
页码:60 / 64
页数:5
相关论文
共 50 条
  • [31] Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey
    Oriol Cunillera
    Ricard Tresserras
    Luis Rajmil
    Gemma Vilagut
    Pilar Brugulat
    Mike Herdman
    Anna Mompart
    Antonia Medina
    Yolanda Pardo
    Jordi Alonso
    John Brazier
    Montse Ferrer
    Quality of Life Research, 2010, 19 : 853 - 864
  • [32] Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey
    Cunillera, Oriol
    Tresserras, Ricard
    Rajmil, Luis
    Vilagut, Gemma
    Brugulat, Pilar
    Herdman, Mike
    Mompart, Anna
    Medina, Antonia
    Pardo, Yolanda
    Alonso, Jordi
    Brazier, John
    Ferrer, Montse
    QUALITY OF LIFE RESEARCH, 2010, 19 (06) : 853 - 864
  • [33] Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2
    Brazier, John E.
    Mulhern, Brendan J.
    Bjorner, Jakob B.
    Gandek, Barbara
    Rowen, Donna
    Alonso, Jordi
    Vilagut, Gemma
    Ware, John E.
    MEDICAL CARE, 2020, 58 (06) : 557 - 565
  • [34] Discriminative aspects of SF-36 and QQL-EPM related to asthma control
    Oliveira, Maria Alenita
    Fernandes, Ana Luisa Godoy
    Santos, Lucia Ande
    Dos Santos Carvalho, Maria Amelia
    Faresin, Sonia Maria
    Santoro, Ilka Lopes
    JOURNAL OF ASTHMA, 2007, 44 (05) : 407 - 410
  • [35] Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights
    Kral, Pavol
    Allen, Felicity Liza
    Larsen, Sara
    Holst-Hansen, Thomas
    Olivieri, Anamaria-Vera
    Manton, Andrew
    DIABETES OBESITY & METABOLISM, 2024, 26 (04): : 1171 - 1179
  • [36] Correlation of SF-12 and SF-36 in a trauma population
    Kiely, JM
    Brasel, KJ
    Guse, CE
    Weigelt, JA
    JOURNAL OF SURGICAL RESEARCH, 2006, 132 (02) : 214 - 218
  • [37] Is Health Preference Derived from the SF-36v2 Equivalent to that Measured by the SF-6D Health Survey?
    Lam, Cindy L.
    Wong, Carlos K.
    Lam, Elegance T.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 105 - 105
  • [38] Valuing the SF-6D Version 2 in Canada
    Bansback, Nick
    Mulhern, Brendan
    Sawatzky, Richard
    Brazier, John
    Whitehurst, David G.
    QUALITY OF LIFE RESEARCH, 2015, 24 : 180 - 181
  • [39] PROMIS PF CAT Outperforms the ODI and SF-36 Physical Function Domain in Spine Patients
    Brodke, Darrel S.
    Goz, Vadim
    Voss, Maren W.
    Lawrence, Brandon D.
    Spiker, William Ryan
    Hung, Man
    SPINE, 2017, 42 (12) : 921 - 929
  • [40] DEVELOPING SF-6D-V2: EXAMINING THE DIMENSIONALITY OF THE SF-36 USING LARGE MULTINATIONAL DATASETS
    Mulhern, B.
    Brazier, J.
    Bjorner, J. B.
    VALUE IN HEALTH, 2015, 18 (03) : A27 - A27